The EU Wants to Transfer the Costs of New Antibiotics to its Member States—They Are Right To Revolt
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why they think its proposed policies are costly, inefficient, and will disrupt the market for generic drugs. They make three counter proposals for how new antimicrobials can be encouraged.
Source: cgdev.org